Cannell Capital LLC Mimedx Group, Inc. Transaction History

Cannell Capital LLC

  • $308 Million
  • Q3 2025

A detailed history of Cannell Capital LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Cannell Capital LLC holds 2,013,840 shares of MDXG stock, worth $14.9 Million. This represents 4.56% of its overall portfolio holdings.

Number of Shares
2,013,840
Previous 2,073,926 2.9%
Holding current value
$14.9 Million
Previous $12.7 Million 10.93%
% of portfolio
4.56%
Previous 4.21%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$6.1 - $7.31 $366,524 - $439,228
-60,086 Reduced 2.9%
2,013,840 $14.1 Million
Q2 2025

Aug 14, 2025
SELL
$5.88 - $7.69 $347,119 - $453,971
-59,034 Reduced 2.77%
2,073,926 $12.7 Million
Q1 2025

May 15, 2025
SELL
$7.54 - $9.28 $11.4 Million - $14 Million
-1,506,585 Reduced 41.39%
2,132,960 $16.2 Million
Q4 2024

Feb 13, 2025
BUY
$5.51 - $9.75 $221,694 - $392,291
40,235 Added 1.12%
3,639,545 $35 Million
Q3 2024

Nov 14, 2024
BUY
$5.65 - $7.76 $1.57 Million - $2.15 Million
277,364 Added 8.35%
3,599,310 $21.3 Million
Q2 2024

Aug 13, 2024
BUY
$6.16 - $8.08 $5.47 Million - $7.18 Million
888,452 Added 36.51%
3,321,946 $23 Million
Q1 2024

May 14, 2024
SELL
$7.61 - $8.63 $361,284 - $409,709
-47,475 Reduced 1.91%
2,433,494 $18.7 Million
Q4 2023

Feb 13, 2024
BUY
$5.7 - $9.14 $1.18 Million - $1.89 Million
207,207 Added 9.11%
2,480,969 $21.8 Million
Q3 2023

Nov 14, 2023
BUY
$6.35 - $8.16 $7.45 Million - $9.58 Million
1,173,506 Added 106.66%
2,273,762 $16.6 Million
Q2 2023

Aug 14, 2023
BUY
$3.14 - $6.61 $2.19 Million - $4.6 Million
696,594 Added 172.57%
1,100,256 $7.27 Million
Q1 2023

May 15, 2023
BUY
$2.97 - $4.81 $1.2 Million - $1.94 Million
403,662 New
403,662 $1.38 Million

About MIMEDX GROUP, INC.

MDXG Quotes by TradingView
  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $838M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Cannell Capital LLC Portfolio

Follow Cannell Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cannell Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email